Inositec has been short-listed together with 10 nominees for the deVigier prize. More info here.

29th March 2016

Mattias Ivarsson appeared in the Science and Healthcare category of the 2016 Forbes 30 under 30 European list.

1st March 2016

Mattias Ivarsson has a vision: he wants to keep a dangerous pathogen in check using an innovative approach. As a Pioneer Fellow, he is now taking his first steps on the path to making that vision a reality. Click here for the article (page 28)

9th December 2015

Three Zurich-based start-ups were awarded this year’s Heuberger Winterthur Start-up Award. The three companies from the Life Sciences field each received CHF 150,000 in prize money. Three other start-ups were awarded CHF 50,000 each. Click here for an article and radio interview in German. Click here for an article in English.

13th November 2015

Check out the newsflash, the >>venture>> website or our video for more information.

18th June 2015

Mattias Ivarsson is committed to fighting a nasty bacterium at the root of many hospital-acquired infections. This article describes the story behind Inositec’s technology and CEO.

10th November 2014

Swiss national radio interviews Mattias Ivarsson about Inositec’s therapeutic approach to treat Clostridium difficile infection (in French).

Audio link

6th November 2014

Inositec’s CEO wins the jury and audience prize at the Falling Walls Lab in Zurich and is invited to attend the Falling Walls Lab Final, Conference and Circle in Berlin!

Press article

24th September 2014

Tages Anzeiger describes the Falling Walls Lab Zurich 2014 and features Mattias Ivarsson (in German).

Press article

24th September 2014

This article provides an accessible description of our therapeutic approach (in German).

23rd July 2012